Life Sciences industry leader joins the region’s Life Science & Healthcare membership organisation
Cambridge, UK: 10 April 2024
About the role
We are seeking an experienced, highly motivated Manager to lead all aspects of the Chemical Biology facility including operational, financial and strategic planning. Your specialist expertise will deliver a world-class service to both internal, external users and commercial partners. You will manage and allocate tasks to technical staff within remit and support other departmental managers, providing appropriate cover during annual leave, sickness, commensurate with the grade.
What you would be doing
Welcome to the Q2 Edition of Our People Pathways Newsletter!
Cambridge Enterprise sits at the heart of one of the world’s leading research ecosystems. As part of the University of Cambridge, we turn academic innovation into real-world impact through licensing, partnerships, spinouts and investment.
We support academics, researchers, staff and students in translating their ideas into practice, helping innovators, experts and entrepreneurs use commercial pathways to develop their work for the benefit of society, the economy, themselves and the University.
TTP is an employee-owned technology and product development consultancy, with a 40-year track record of partnering with ambitious clients to solve complex challenges and bring innovative, commercially successful solutions to market.
We invent, design, and manufacture impactful products and technologies across a wide range of industries – including healthcare, life science, energy, and communications – and at the intersection of engineering, physical science, and biology.
The UK Health Security Agency (UKHSA) prevents, prepares for and responds to infectious diseases, and environmental hazards, to keep all our communities safe, save lives and protect livelihoods.
We provide scientific and operational leadership, working with local, national and international partners to protect the public’s health and build the nation’s health security capability.
BURLINGAME, Calif., May 20, 2026 /PRNewswire/ -- Collaborative Drug Discovery (CDD), the leading provider of data management solutions for the pharmaceutical and biotechnology industries, today announced an agreement with Eli Lilly and Company (Lilly) to integrate Lilly TuneLab, a collaborative AI/ML drug discovery platform, into CDD Vault.
This webinar will discuss the impact of the Enlarged Board Simulation decision G1/19 and the UK Supreme Court Judgment in Emotional Perception on practice at the EPO and the UK IPO, particularly looking at appeal decisions. Although generally endorsing prior case law, G1/19 has prompted a greater level of concentration on ensuring that the requirements of patentability, especially technical character, are met over the whole scope of the claims. Emotional Perception directs UK examiners and courts to follow EPO practice more closely.
07:30 Departure to Cambridge
LONDON, UK, and COPENHAGEN, Denmark – May 14, 2026 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully led a search for Neumirna Therapeutics (“Neumirna”) and is pleased to announce the placement of Dr. Ferenc Tracik as Chief Medical Officer (CMO).